Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Nurse-trainer Helena Cumbelembe Inacio was struggling to teach nurses at the health center here the correct combination of medicines to prevent pregnant women with HIV from passing the infection to their children. The nurses couldn't quite master the medication protocol. "The learning is slow, and they could not pronounce well the names of the [antiretroviral] drugs, let alone to remember the combination of the drugs," Cumbelembe Inacio recalled.

Angola's Institute for the Fight Against AIDS had taken the bold step of accelerating a plan to expand Option B+, an approach recommended by the World Health Organization to offer all pregnant and breastfeeding women who are HIV-positive a combination regimen of three antiretrovirals immediately upon diagnosis that they would continue to take for life.

The nurses at the facility, a four-hour ride from the central city of Huambo, had the essential skills to care for patients but had not had refresher training in many years, and this new area of HIV treatment proved to be daunting. "I said, well, maybe through a song they will learn the names and the combination." So, Cumbelembe Inacio and fellow trainer Dinis Cardoso reworked the lyrics of the French nursery rhyme Frère Jacques to follow the three-drug treatment regimen of Tenofovir (TDF), Lamivudine (3TC), and Efavirenz.

Esquema preferencial: Te-De-Efe, Te-De-Efe, Tres t-ce, Tres t-ce, Efavirense, Efavirense, mistura, mistura

[Translation: Preferred regimen: TDF, 3TC, Efavirenz combined]

"The nurses sang and danced, the names stuck, and they could remember the combination very well," recalled Cumbelembe Inacio. "Even when we went back for supervision they recited the [regimen] correctly."

Source:

Johns Hopkins Hospital and Health System

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Researchers identify targeted therapy for adolescent patients with neuroblastoma